4.5 Article

Hydroxy-3,4-dehydro-apo-8′-lycopene and methyl hydroxy-3,4-dehydro-apo-8′-lycopenoate, novel C30 carotenoids produced by a mutant of marine bacterium Halobacillus halophilus

Journal

JOURNAL OF ANTIBIOTICS
Volume 63, Issue 6, Pages 291-295

Publisher

JAPAN ANTIBIOTICS RESEARCH ASSOC
DOI: 10.1038/ja.2010.33

Keywords

antioxidative activity; chemical mutagenesis; Halobacillus halophilus; hydroxy-3,4-dehydro-apo-8 '-lycopene; methyl hydroxy-3,4-dehydro-apo-8 '-lycopenoate

Funding

  1. European Commission [FP7-KBBE-2007-207948]
  2. German Science Foundation (DFG)

Ask authors/readers for more resources

We performed the chemical mutagenesis of Halobacillus halophilus (the producer of a C-30 carotenoid, methyl glucosyl-3,4-dehydro-apo-8'-lycopenoate) to isolate novel carotenoids that are biosynthetic intermediates of methyl glucosyl-3,4-dehydro-apo-8'-lycopenoate. As a result, we isolated two novel C-30 carotenoids, hydroxy-3,4-dehydro-apo-8'-lycopene and methyl hydroxy-3,4-dehydro-apo-8'-lycopenoate, which were biosynthesized through a novel 8'-apo C-30 pathway. These carotenoids showed antioxidative activity in the O-1(2) suppression model. The Journal of Antibiotics (2010) 63, 291-295; doi:10.1038/ja.2010.33; published online 23 April 2010

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available